QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Writing the Data in Summary Tabulations Section in a PBRER

Test your understanding of the concepts covered by Writing the Data in Summary Tabulations Section in a PBRER.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A two-to-four case increase is observed for a rare event in a product with limited exposure. Which interpretation is most scientifically appropriate?

The risk has increased by 100% The increase is irrelevant because the absolute number is small The change may reflect random variation, but the clinical nature of the event determines whether review is warranted The finding automatically demonstrates a signal

Question 2 of 10 Which additional evidence would most appropriately support interpretation of an unusual pattern identified in summary tabulations?

Only the percentage change in the relevant PT Individual case review together with relevant clinical, epidemiological, literature, or regulatory evidence The fact that the report was generated by validated software A comparison with an unrelated medicinal product

Question 3 of 10 Which database activity could create an apparent trend by changing the content of the cumulative dataset?

Migration of historical partner cases into the global safety database Maintaining the same extraction criteria and database scope Reviewing the report against the applicable Data Lock Point Using a validated database extraction process

Question 4 of 10 Why must duplicate detection and reconciliation be considered before interpreting differences between reporting periods?

Duplicates are used to estimate patient exposure Duplicate handling can change counts without reflecting a change in the product's safety profile Duplicate reports are always excluded from all pharmacovigilance analyses Duplicate reconciliation determines the product's approved indications

Question 5 of 10 Which statement best describes the relationship between the summary tabulations section and the overall PBRER benefit-risk evaluation?

The tabulations are the sole basis for the benefit-risk conclusion The tabulations provide one structured source of evidence that may influence the depth and direction of later assessment The benefit-risk evaluation should be completed before reviewing the tabulations The tabulations are administrative and have no relevance to later PBRER sections

Question 6 of 10 Which factor is most relevant when evaluating whether an apparent increase represents disproportionate reporting after accounting for exposure?

Whether the observation is medically important and inconsistent with the recognised safety profile Whether the table contains exactly the same number of rows as the previous report Whether the event was reported by a healthcare professional rather than a patient Whether the product has been marketed for more than one year

Question 7 of 10 Why should absence of an important change in summary tabulations not be treated as evidence that no new safety information exists?

Because tabulations include only efficacy outcomes Because new information may arise from trials, PASS, literature, regulatory communications, or other sources not reflected as a notable tabulation change Because summary tabulations are never cumulative Because only individual cases can be used in a PBRER

Question 8 of 10 A reviewer observes that reports for a Preferred Term doubled during the interval. Which initial interpretation is most appropriate?

The underlying risk has doubled The adverse reaction is now confirmed as a safety signal The increase is an observation requiring assessment of exposure, reporting, coding, and database factors The increase should be excluded because Preferred Terms cannot be reviewed in a PBRER

Question 9 of 10 Which characteristic would make a cluster of reports more concerning than an increase consisting of unrelated cases sharing only a PT?

The cases have similar clinical presentations, timing, risk factors, and outcomes The cases were received from different data sources The cases were all entered on different dates The cases involve several different MedDRA SOCs with no clinical relationship

Question 10 of 10 What is the appropriate role of summary tabulations in signal evaluation?

They independently confirm or refute every potential signal They identify observations that may guide subsequent evaluation using broader evidence They replace individual case narratives and epidemiological studies They provide direct estimates of the incidence rate for each event

QPPV.com

Knowledge Assessment: Writing the Data in Summary Tabulations Section in a PBRER

Cookie Settings